TGF-β/SMAD signaling activation directly induces G1 cell cycle arrest in tumor cells, leading to tumor proliferating cancer cells (TPCs) entering a quiescent state, protecting cancer cells from cellular DNA damage caused by 5-FU, and therefore inducing drug resistance [118]. The gene discussed is TGFB1; the disease is neoplasm.